Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Decision making is evidence based and must be shielded from lobbying The NHS draft recommendation against routine prostate ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

READ MORE: Scandal of NHS prostate cancer postcode lottery: Thousands of men at greater risk of death as 96 trusts fail to meet target to start treatment, forcing hundreds to wait months for care A ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

Prostate cancer screening should not be made routinely available for the vast majority of men in the UK, a committee advising the Government has said. In a draft recommendation, the UK National ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.